Estrogen-related receptor α1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway

Molecular Cancer Research

Volumn 5, Issue 1, 2007, Pages 71-85

  Ariazi, Eric A ^a   Kraus, Richard J ^a   Farrell, Michael L ^a   Jordan, V Craig ^b   Mertz, Janet E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA 1; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN PS2; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHORYLATION; PRESENILIN-2; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 33846951523     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0227     Document Type: Article

References (51)

1. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-3.
2. Ariazi EA, Ariazi JL, Cordera F, Jordan VC. Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 2006;6:195-216.
3. Ariazi EA, Jordan VC, Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem 2006;6:181-93.
4. Yang N, Shigeta H, Shi H, Teng CT, Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J Biol Chem 1996;271:5795-804.
5. Johnston SD, Liu X, Zuo F, et al. Estrogen-related receptor α1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol Endocrinol 1997;11:342-52.
6. Vanacker JM, Bonnelye E, Chopin-Delannoy S, Delmarre C, Cavaillès V, Laudet V. Transcriptional activities of the orphan nuclear receptor ERRα (estrogen receptor-related receptor α). Mol Endocrinol 1999;13:764-73.
7. Vanacker JM, Pettersson K, Gustafsson JÅ, Laudet V. Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ. EMBO J 1999;18:4270-9.
8. Kraus RJ, Ariazi EA, Farrell ML, Mertz JE. Estrogen-related receptor α1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. J Biol Chem 2002;277:24826-34.
9. Sladek R, Bader JA, Giguère V. The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 1997;17:5400-9.
10. Barry JB, Laganière J, Giguère V. A single nucleotide in an estrogen-related receptor α site can dictate mode of binding and peroxisome proliferator-activated receptor γ coactivator 1α activation of target promoters. Mol Endocrinol 2006;20:302-10.
11. Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002;62:6510-8.
12. Suzuki T, Miki Y, Moriya T, et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res 2004;64:4670-6.
13. Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1α (PGC-1α) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and -γ: identification of novel leucine-rich interaction motif within PGC-1α. J Biol Chem 2002;277:40265-74.
14. Kallen J, Schlaeppi JM, Bitsch F, et al. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α. J Biol Chem 2004;279:49330-7.
15. Xie W, Hong H, Yang NN, et al. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol Endocrinol 1999;13:2151-62.
16. Zhang Z, Teng CT. Estrogen receptor-related receptor α1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 2000;275:20837-46.
17. Chen S, Zhou D, Yang C, Sherman M. Molecular basis for the constitutive activity of estrogen-related receptor α-1. J Biol Chem 2001;276:28465-70.
18. Lu D, Kiriyama Y, Lee KY, Giguère V. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res 2001;61:6755-61.
19. Yang C, Zhou D, Chen S. Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor. Cancer Res 1998;58:5695-700.
20. Seely J, Amigh KS, Suzuki T, et al. Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor α (ERRα). Endocrinology 2005;146:3605-13.
21. Vanacker JM, Delmarre C, Quo X, Laudet V. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related a. Cell Growth Differ 1998;9:1007-14.
22. Liu D, Zhang Z, Gladwell W, Teng CT. Estrogen stimulates estrogen-related receptor α gene expression through conserved hormone response elements. Endocrinology 2003;144:4894-904.
23. Laganière J, Tremblay GB, Dufour CR, et al. A polymorphic autoregulatory hormone response element in the human estrogen-related receptor α (ERRα) promoter dictates peroxisome proliferator-activated receptor γ coactivator-1α control of ERRa expression. J Biol Chem 2004;279:18504-10.
24. Herzog B, Cardenas J, Hall RK, et al. Estrogen-related receptor α is a repressor of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 2006;281:99-106.
25. Grant S, Qiao L, Dent P. Roles of ErbB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Front Biosci 2002;7:d376-89.
26. Lannigan DA. Estrogen receptor phosphorylation. Steroids 2003;68:1-9.
27. McClelland RA, Barrow D, Madden TA, et al. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICT 182,780 (Faslodex). Endocrinology 2001;142:2776-88.
28. Benz CC, Scott GK, Sarup JC, et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat 1992;24:85-95.
29. Coutts AS, Murphy LC. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res 1998;58:4071-4.
30. Wright C, Nicholson S, Angus B, et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer 1992;65:118-21.
31. Houston SJ, Plunkett TA, Barnes DM, Smith P, Rubens RD, Miles DW. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer. Br J Cancer 1999;79:1220-6.
32. Dowsett M, Harper-Wynne C, Boeddinghaus I, et al. HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. Cancer Res 2001;61:8452-8.
33. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 1987;6:605-10.
34. Leyland-Jones B. Trastuzumab: hopes and realities. Lancet Oncol 2002;3:137-44.
35. Moulder SL, Yakes FM, Muthuswamy SK, Bianco R, Simpson JF, Arteaga CL. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res 2001;61:8887-95.
36. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-32.
37. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-8.
38. Barry JB, Giguère V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor α. Cancer Res 2005;65:6120-9.
39. HER-2 Overexpression, and intratumor heterogeneity in human breast cancer. Cancer Res 1995;55:5400-7.
40. Carlson RW. The history and mechanism of action of fulvestrant. Clin Breast Cancer 2005;6(Suppl 1):S5-8.
41. Périer RC, Praz V, Junier T, Bonnard C, Bucher P. The eukaryotic promoter database (EPD). Nucleic Acids Res 2000;28:302-3.
42. Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN. Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains. Cancer Res 1991;51:5649-54.
43. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem 2001;276:22177-82.
44. Castet A, Herledan A, Bonnet S, Jalaguier S, Vanacker JM, Cavaillès V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinology 2006;20:1035-47.
45. Zhang Z, Teng CT. Estrogen receptor α and estrogen receptor-related receptor α1 compete for binding and coactivator. Mol Cell Endocrinol 2001;172:223-33.
46. Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol 1992;90:77-86.
47. Levenson AS, Jordan VC. MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 1997;57:3071-8.
48. Katzenellenbogen JA, Johnson HJ, Jr., Myers HN. Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry 1973;12:4085-92.
49. Rogatsky I, Zarember KA, Yamamoto KR. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 2001;20:6071-83.
50. 2. Prostate 2003;55:159-67.
51. O'Reilly GH. Regulation of the SV40 late promoter by nuclear receptors and large T antigen. Genetics. Madison: University of Wisconsin-Madison; 2000.